The role of human leukocyte antigen tissue groups inhepatitis B virus vaccination in Turkey

Journal of Microbiology, Immunology and Infection

Volumn 47, Issue 1, 2014, Pages 9-14

  Mert, Gurkan ^a   Sengul, Ali ^b   Gul, Hanefi Cem ^a   Karakas, Ahmet ^a   Eyigun, Can Polat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b MEDICAL PARK HOSPITAL   (Turkey)

Author keywords

Hepatitis B vaccines; HLA DR; Human leukocyte antigen; Nonresponse

Indexed keywords

HEPATITIS B VACCINES; HLA-DR; HUMAN LEUKOCYTE ANTIGEN; NONRESPONSE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPLOTYPES; HEPATITIS B; HEPATITIS B VACCINES; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; TURKEY; YOUNG ADULT;

EID: 84894434624     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.01.004     Document Type: Article

References (31)

1. Coates T., Wilson R., Patrick G., André F., Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 2001, 23:392-403.
2. Assad S., Francis A. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine 1999, 18:57-67.
3. Desombere I., Van der Wielen M., Van Damme P., Stoffel M., De Clercq N., Goilav C., et al. Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant. Vaccine 2002, 20:2597-2602.
4. Stephens H.A., Brown A.E., Chandanayingyong D., Webster H.K., Sirikong M., Longta P., et al. The presence of the HLA Class-II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen. Eur J Immunol 1995, 25:3142-3147.
5. Crosnier J., Jungers P., Couroucé A.M., Laplanche A., Benhamou E., Degos F., et al. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II, Haemodialysis patients. Lancet 1981, 1:797-800.
6. Stevens C.E., Alter H.J., Taylor P.E., Zang E.A., Harley E.J., Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984, 311:496-501.
7. Craven D.E., Awdeh Z.L., Kunches L.M., Yunis E.J., Dienstag J.L., Werner B.G., et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med 1986, 105:356-360.
8. Weissman J.Y., Tsuchiyose M.M., Tong M.J., Co R., Chin K., Ettenger R.B. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine. JAMA 1988, 260:1734-1738.
9. Pol S., Legendre C., Mattlinger B., Berthelot P., Kreis H. Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients. J Hepatol 1990, 11:385-387.
10. Varla-Leftherioti M., Papanicolaou M., Spyropoulou M., Vallindra H., Tsiroyianni P., Tassopoulos N., et al. HLA-associated non-responsiveness to hepatitis B vaccine. Tissue Antigens 1990, 35:60-63.
11. Alper C.A., Kruskall M.S., Marcus-Bagley D., Craven D.E., Katz A.J., Brink S.J., et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989, 321:708-712.
12. McDermott A.B., Zuckerman J.N., Sabin C.A., Marsh S.G., Madrigal J.A. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997, 50:8-14.
13. Watanabe H., Matsushita S., Kamikawaji N., Hirayama K., Okumura M., Sasazuki T. Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells. Hum Immunol 1988, 22:9-17.
14. Watanabe H., Okumura M., Hirayama K., Sasazuki T. HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells. Tissue Antigens 1990, 36:69-74.
15. Hatae K., Kimura A., Okubo R., Watanabe H., Erlich H.A., Ueda K., et al. Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype. Eur J Immunol 1992, 22:1899-1905.
16. Terasaki P.I., Bernoco D., Park M.S., Ozturk G., Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol 1978, 69:103-120.
17. Buyse I., Decorte R., Baens M., Cuppens H., Semana G., Emonds M.P., et al. Rapid DNA typing of Class-II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993, 41:1-14.
18. Desombere I., Willems A., Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998, 51:593-604.
19. Langö-Warensjö A., Cardell K., Lindblom B. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen. Tissue Antigens 1998, 52:374-380.
20. Durupinar B., Okten G. HLA tissue types in nonresponders to hepatitis B vaccine. Indian J Pediatr 1996, 63:369-373.
21. Arslanoǧlu I., Cetin B., Işgüven P., Karavus M. Anti-HBs response to standard hepatitis B vaccination in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab 2002, 15:389-395.
22. Leroy V., Bourliere M., Durand M., Abergel A., Tran A., Baud M., et al. The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control study. Eur J Gastroenterol Hepatol 2002, 14:485-489.
23. Tele S.A., Martins R.M., Lopes C.L., dos Santos Carneiro M.A., Souza K.P., Yoshida C.F. Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff. Eur J Epidemiol 2001, 17:145-149.
24. Zuckerman J.N. Hepatitis B third-generation vaccines: improved response and conventional vaccine non-response-third generation pre-S/S vaccines overcome non-response. J Viral Hepat 1998, 5(Suppl. 2):13-15.
25. Ayed K., Bardi R., Gebuhrer L., Gorgi Y., Betuel H. HLA-A, B, C and DR antigens in a sample of the Tunisian population. Tissue Antigens 1987, 29:225-231.
26. Alper C.A., Awdeh Z., Raum D., Yunis E.J. Complement genes of the major histocompatibility complex (complotypes), extended haplotypes and disease markers. Biochem Soc Symp 1986, 51:19-28.
27. Pachoula-Papasteriadis C., Ollier W., Cutbush S., Economidou J., Festenstein H. HLA antigen and haplotype frequencies in Greeks. Tissue Antigens 1989, 33:488-490.
28. Uyar F.A., Dorak M.T., Saruhan-Direskeneli G. Human leukocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: relationship to other populations. Tissue Antigens 2004, 64:180-187.
29. Aydogan K., Karadogan S.K., Akdag I., Tunali S. HLA class I and Class-II antigens in Turkish patients with chronic ordinary urticaria. Clin Exp Dermatol 2006, 31:424-429.
30. Stachowski J., Kramer J., Füst G., Maciejewski J., Baldamus C.A., Petrányi G.G. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Scand J Immunol 1995, 42:60-65.
31. Yap I., Chan S.H. A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation. Ann Acad Med Singapore 1996, 25:120-122.